Analyst firms · Morgan Stanley · IRTC

Morgan Stanley IRTC price target and rating history

iRhythm Holdings Inc. (IRTC) · Health Care

Morgan Stanley rates iRhythm Holdings Inc. (IRTC) Overweight with a $151 price target, as of its latest action on Feb 24, 2022. It has published 4 rating actions on IRTC since November 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.

Current rating
Overweight
Price target
$151
Median target, all firms
$160
Actions on IRTC
4

Morgan Stanley price target on IRTC

$167$141$11420222023202420252026
Morgan Stanley price target on IRTC, each point a stated target, November 2021 to February 2022.

Every Morgan Stanley rating on IRTC

How other firms rate IRTC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
CitigroupNeutral$124Nov 6, 2026
Piper SandlerOverweight$160Oct 16, 2026
StephensOverweight$160Jul 23, 2026
Evercore ISIOutperform$210Jan 5, 2026

Questions about Morgan Stanley and IRTC

What is Morgan Stanley's price target for IRTC?
Morgan Stanley's latest stated price target for iRhythm Holdings Inc. (IRTC) is $151, from its action on Feb 24, 2022.
What is Morgan Stanley's rating on IRTC?
Morgan Stanley rates IRTC Overweight, a bullish rating, as of Feb 24, 2022.
When did Morgan Stanley last change its view on IRTC?
On Feb 24, 2022, Morgan Stanley cuts its price target to $151 from $167, keeps Overweight.
How does Morgan Stanley's IRTC target compare with other analysts?
Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.

More IRTC rating histories

All Morgan Stanley ratingsIRTC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.